Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Ahmed Neuro 2 Depression > Lecture 14: Narcotic Analgesics > Flashcards

Lecture 14: Narcotic Analgesics Flashcards

1
Q

Which opioid agonist is used for pulmonary edema?

A

Morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which 2 opioid agonists are used for severe pain and as an adjunct in anesthesia?

A
  • Fentanyl
  • Morphine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the MOA on both the presynaptic μ-receptor and post-synaptic μ-receptor by opioids?

A
  • Presynaptic μ-receptor activation INHIBITS Ca2+ influx into sensory neurons, which decreases NT release
  • Post-synaptic μ-receptor activation INCREASES K+ efflux, which decreases postsynaptic response to excitatory neurotransmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 opioids which are strong μ-receptor agonists?

A
  1. Morphine
  2. Fentanyl
  3. Methodone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the pharmacokinetics of the strong opioid agoinsts?

Exception?

A
  • First pass effect
  • Duration 1-4 hours
  • Except methadone = 4-6 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What’s the MOA of Codeine and Hydrocodone, as compared to the strong opioid agonists?

A
  • Less efficaious than morphine, partial μ-receptor agonists
  • Can antagonize strong agonist
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the clinical applications of Codeine and Hydrocodone?

A
  • Mild-moderate pain
  • Cough (codeine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the 2 opioids belonging to the class of mixed opioid agonist-antagonist?

A
  • Buprenorphine
  • Nalbuphine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are effects of the opioids, Buprenorphine and Nalbuphine?

A
  • Like strong agonists, but can antagonize their effects
  • Also reduces craving for alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Buprenorphine used for clinically?

A
  • Moderate pain
  • Some maintenane rehabilitation programs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the duration of action for Buprenorphine and Nalbuphine and associated toxicity?

A
  • Long duration of action: 4-8 hours
  • May precipitate abstinence syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the clinical application for the use of the opioid, Nalbuphine?

A

Moderate pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the effect of Dextromethorphan?

A
  • Reduces cough reflex
  • Not an analgesic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Dextromethorphan used for?

A

Acute debilitating cough

*This is Nyquil or Robitussin = Antitussives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the MOA of Naloxone?

A

Strong antagonist of μ, δ, and k receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is clinical application for Naloxone?

A

Opioid overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is a potential toxicity associated with Naloxone?

A

Precipitates abstinence (withdrawl) syndrome in dependent users

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the MOA of the analgesic, Tapentadol?

A
  • Moderate μ agonist
  • Strong NET inhibitor
19
Q

What is Tapentadol used for clinically?

A

Moderate pain

20
Q

What are some of the toxicities/consequences associated with Tapentadol?

A
  • Headache; nausea and vomiting
  • Possible dependence
21
Q

What is the MOA of the analgesic, Tramadol?

A
  • Weak μ agonist
  • Moderate SERT inhibitor
  • Weak NET inhibitor

*Mixed effects

22
Q

What is the clinical application of Tramadol?

A
  • Moderate pain
  • Adjunct to opioids in chronic pain syndromes
23
Q

What are some of the potential toxicities associated with Tramadol?

A
  • Seizures
  • Risk of serotonin syndrome
24
Q

What is the MOA of Naltrexone and Nalmefene; how are they different from Naloxone?

A
  • Strong antagonist of μ, δ and k receptors (just like Naloxone)
  • Longer duration of action (10 hours!)
25
What are some of the clinical applications of Naltrexone?
- Maintenance programs and can block heroin effects for up to 48 h - Used for alcohol and nicotine dependence \*When combined with bupropion may be effective in weight-loss programs
26
What are the functions/downstream effects caused by activation of the μ-receptor?
- Supraspinal and spinal analgesia - Sedation - Inhibition of respiration - Slowed GI transit - Modulation of hormone and NT release
27
What are the functions/downstream effects caused by activation of the δ-receptor?
- Supraspinal and spinal analgesias - Modulation of hormone and NT release
28
What are the functions/downstream effects caused by activation of the k-receptor?
- Supraspinal and spinal analgesias - Psychotomimetic effects - Slowed GI transit
29
What is the endogenous opioid peptide affinity for μ, δ, and k-receptor (endorphins, dynorphins, and enkephalins?
- **μ-receptor:** Endorphins \> enkephalins \> dynorphins - **δ-receptor:** Enkephalins \> endorphins and dynorphins - **k-receptor:** Dynorphins \>\> endorphins and enkephalins
30
What is the MOA of Nalbuphine?
- **k**-receptor **agonist** - **μ**-receptor **antagonist** \*Mixed opioid agonist-antagonist
31
What is the MOA of Buprenorphine?
- Partial/weak **μ**-receptor **agonist** - **k**-receptor **antagonist** \*Mixed opioid agonist-antagonist
32
Which 5 opioids are partial or weak agonists of μ-receptors?
- Hydrocodone - Codeine - Pentazocine - Buprenorphine - Butorphanol
33
Which opioid is a **strong k-receptor agonist** and partial/weak agonist of μ-receptors; and can only be given **parenterally**?
Butorphanol
34
What are some of the adverse effects associated w/ acute use of opioids?
- Respiratory depression - Nausea/vomiting - Pruritus/Uticaria - Constipation and Urinary retention - Delirium -- Sedation - Myoclonus - Seizures
35
What are some of the adverse effects associated w/ chronic use of opioids?
- Hypogonadism - Immunosuppression - Increased feeding - Increased GH secretion - Withdrawl effects - Tolerance, dependence --\> Abuse, addiction - Hyperalgesia (**increased sensitivity to pain**) - Imapirment while driving
36
What are the relative contraindications for morphine?
- Acute **respiratory depression** - **Renal failure** (due to accumulation of the metabolites morphine-3-glucuronide and **morphine-6-glucuronide**) - Chemical **toxicity** (potentially lethal in **low tolerance** patients) - Raised ICP, including head injury (risk of **worsening** respiratory depression) - **Biliary colic**
37
How does the physiological state of obesity play a role in the pharmacokinetic variance in use of narcotic analgesics?
- Overdosage - Central Vd is **not** reflected by ABW - **Increased adipose tissue** causes and **increase in total Vd ---\>** prolongs elimination half-life
38
What are 2 pharmacokinetic variances in the elderly that must be accounted for when administering narcotic analgesics?
1) **Decreased neuronal mass** and **decreased central Vd** ---\> **Increased** **sensitivity** to opioids 2) **Decreased LBM** w/ **increased adipose tissue** causes **increase in total Vd** + **Decreased Hepatic Blood Flow** (by 40-50% age 75) --\> **Prolongs** effect of infusion
39
What pharmacokinetic variances in infants need to be accounted for when administering narcotic analgesics?
**Decreased** conjugation capacity and **immature** renal function ---\> **Prolonged** effect
40
By what mechanism may renal failure lead to morphine toxicity?
- Accumulation of **Morphine-6-Glucuronide (M6G)** - Possible hydrolysis of glucuronides back to **parent compound** - **Uraemia** potentiates CNS depression and increased BBB permeability
41
Renal failure may lead to Pethidine toxicity due to the accumulation of \_\_\_\_\_\_\_\_\_\_
Norpethidine
42
What is the mechanism by which severe liver failure may lead to increase sensitivity to opioids? There may be synergism when? Which drugs will have an increased elimination half-life?
- Synergism if **encephalopathic** - **Altered integrity of BBB** - Increased elimination half-life for **pethidine** and **tramadol**
43
Which 3 genes related to opioid receptors and signal transduction have been implicated as genetic factors in the Pharmacodynamics of Opioids?
- *OPRM1* - *COMT* - *MC1R*
44
Which genes related to metabolizing enzymes and transporters have been implicated in the variation of the Pharmacokinetic profile of Opioids?
- *CYP2D6* and *UGT2B7* ---\> **Metabolizing enzymes** - *ABCB1* ---\> **Transporter**

Ahmed Neuro 2 Depression (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions